Citation Impact
Citing Papers
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Cancer statistics, 2024
2024 Standout
Methods for evaluation of platelet function
2009 StandoutNobel
Platelet pharmacogenomics
2010
Smoking and cancer‐related gene expression in bronchial epithelium and non‐small‐cell lung cancers
2006
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
2006
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Glutathione peroxidases
2012 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*
2005
Chronic myelogenous leukemia
2001
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Cancer genetics of epigenetic genes
2007
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
2005
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100
2007
Models, mechanisms and clinical evidence for cancer dormancy
2007
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions
2021
Cancer genes and the pathways they control
2004 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Detection of minimal residual disease
2001
Chronic Myelogenous Leukemia
2002
Emerging Biological Principles of Metastasis
2017 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Wnt/β-Catenin Signaling in Development and Disease
2006 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
Microenvironmental regulation of metastasis
2008 Standout
Clonal evolution in cancer
2012 StandoutNature
Aspirin resistance
2006
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Epigenetic modifications and human disease
2010 Standout
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
The genetics of antiplatelet drug resistance
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism
2002
Wnt signalling in stem cells and cancer
2005 StandoutNature
Cancer as an evolutionary and ecological process
2006 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
2004
Peripheral T- cell lymphomas: diagnosis and management
2003
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Tumour stem cells and drug resistance
2005 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases [see comments]
1995
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
1996 Standout
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
2004 StandoutScience
Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia
2001
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
2006
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene
1996
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Large-scale analysis of the human and mouse transcriptomes
2002 StandoutNobel
Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML
2006
Works of André Brizard being referenced
Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside
1991
Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms
2003
E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype
2002
Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia
1998
Persistence of Transcriptionally Silent BCR-ABL Rearrangements in Chronic Myeloid Leukemia Patients in Sustained Complete Cytogenetic Remission
2001
Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T‐prolymphocytic leukaemia: four new cases and a review of the literature
1994
Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)
2001
Translocation (8;9)(q12;p21)
1990
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCRexpression, elevated BCR-ABL levels, or karyotypic instability
2002
Double-Gradient–Denaturing-Gradient Gel Electrophoresis for Mutation Screening of the BCR-ABL Tyrosine Kinase Domain in Chronic Myeloid Leukemia Patients
2005
Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation
2000
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
1995